Bio-Techne

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.

About TECH

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. 

CEO
Kim Kelderman
CEOKim Kelderman
Employees
3,100
Employees3,100
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
1976
Founded1976
Employees
3,100
Employees3,100

TECH Key Statistics

Market cap
8.35B
Market cap8.35B
Price-Earnings ratio
101.65
Price-Earnings ratio101.65
Dividend yield
0.61%
Dividend yield0.61%
Average volume
2.03M
Average volume2.03M
High today
$54.10
High today$54.10
Low today
$52.29
Low today$52.29
Open price
$52.29
Open price$52.29
Volume
1.84M
Volume1.84M
52 Week high
$72.16
52 Week high$72.16
52 Week low
$46.01
52 Week low$46.01

Stock Snapshot

As of today, Bio-Techne(TECH) shares are valued at $53.40. The company's market cap stands at 8.35B, with a P/E ratio of 101.65 and a dividend yield of 61.2%.

As of 2026-04-01, Bio-Techne(TECH) stock has fluctuated between $52.29 and $54.10. The current price stands at $53.40, placing the stock +2.1% above today's low and -1.3% off the high.

The Bio-Techne(TECH)'s current trading volume is 1.84M, compared to an average daily volume of 2.03M.

During the past year, Bio-Techne(TECH) stock moved between $46.01 at its lowest and $72.16 at its peak.

During the past year, Bio-Techne(TECH) stock moved between $46.01 at its lowest and $72.16 at its peak.

TECH News

Simply Wall St 2d
Bio-Techne’s New COMET Spatial Tools Might Change The Case For Investing In Bio-Techne

In March 2026, Bio-Techne Corporation expanded its COMET spatial biology portfolio by introducing new SPYRE Focus Panels, SPYRE Amplification Kits using seqLA t...

Bio-Techne’s New COMET Spatial Tools Might Change The Case For Investing In Bio-Techne
Simply Wall St 4d
Is It Time To Revisit Bio-Techne After Recent Share Price Weakness?

Wondering whether Bio-Techne at around US$50.95 is starting to look interesting, or if the price still does not line up with its underlying value. The stock ha...

Is It Time To Revisit Bio-Techne After Recent Share Price Weakness?
Simply Wall St 6d
Bio Techne Spatial Biology Expansion And What It Could Mean For Valuation

Bio-Techne, ticker NasdaqGS:TECH, has expanded its COMET spatial biology workflow with new SPYRE Focus Panels and Amplification Kits. The company has also rele...

Bio Techne Spatial Biology Expansion And What It Could Mean For Valuation

Analyst ratings

67%

of 18 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own TECH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.